Biting the invisible hand

Biting the invisible hand

The workings of the market can be an ugly sight seen up close. Good companies can't raise enough money and their valuations are too low; dubious companies can raise more than they deserve at valuations that are too high; and everyone knows there are far more companies than the bioscience sector can sustain.

As this latest offerings window has creaked open, there

Read the full 657 word article

How to gain access

Continue reading with a
two-week free trial.